In the present study, treatment with 100 mg/kg EGCG significantly reduced the expression of p-eIF2α, ATF4, CHOP, and Caspase-3, confirming its efficacy in alleviating hyperthyroidism-induced ovarian ERS and suppressing apoptosis. The gene discussed is EIF2A; the disease is hyperthyroidism.